Tian Wang
Investor Relations Kontakt bei Beijing Mabworks Biotech Co., Ltd.
Profil
Tian Wang is currently working as the Joint Secretary at Beijing Mabworks Biotech Co., Ltd.
since 2020.
Prior to this, Mr. Wang worked as a Manager at Zero2ipo Management Consulting Group Co. Ltd.
from 2016 to 2019.
Mr. Wang completed their graduate degree at the University of London in 2014 and their undergraduate degree at Newcastle University in 2013.
Aktive Positionen von Tian Wang
Unternehmen | Position | Beginn |
---|---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Investor Relations Kontakt | 01.03.2019 |
Ehemalige bekannte Positionen von Tian Wang
Unternehmen | Position | Ende |
---|---|---|
Zero2ipo Management Consulting Group Co. Ltd. | Corporate Officer/Principal | 01.03.2019 |
Ausbildung von Tian Wang
University of London | Graduate Degree |
Newcastle University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Beijing Mabworks Biotech Co., Ltd.
Beijing Mabworks Biotech Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Mabworks Biotech Co., Ltd. engages in the discovery, development, manufacturing and commercialization of therapeutic antibodies. It develops antibody drugs and macromolecular biological drugs. The firm’s products include MIL60, MIL62, MIL86, MBS301, MIL77, and MIL93. The company was founded on February 27, 2003 and is headquartered in Beijing, China. | Health Technology |
Zero2ipo Management Consulting Group Co. Ltd. |